-
3
-
-
0035793685
-
AIDS vaccine shows promise after years of frustration
-
(2001)
Science
, vol.291
, pp. 1686-1688
-
-
Cohen, J.1
-
6
-
-
0033807578
-
Human immunodeficiency virus vaccine development in developing countries: Are efficacy trials feasible?
-
(2000)
J Hum Virol
, vol.3
, pp. 193-214
-
-
Excler, J.L.1
Beyrer, C.2
-
8
-
-
0034116325
-
Ethical challenges of HIV vaccine trials in less developed nations: Conflict and consensus in the international arena
-
(2000)
AIDS
, vol.14
, pp. 1051-1057
-
-
Bayer, R.1
-
12
-
-
0033009094
-
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study
-
(1999)
AIDS
, vol.13
-
-
Lorenzi, P.1
Opravil, M.2
Hirschel, B.3
Chave, J.P.4
Furrer, H.J.5
Sax, H.6
Perneger, T.V.7
Perrin, L.8
Kaiser, L.9
Yerly, S.10
-
19
-
-
0029590776
-
Effects of non-nucleosides inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assay
-
(1995)
J Biol Chem
, vol.270
, pp. 31046-31051
-
-
Gu, Z.1
Quan, Y.2
Li, Z.3
-
21
-
-
0033022106
-
Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development
-
(1999)
AIDS
, vol.13
, pp. 661-667
-
-
Palmer, S.1
Shafer, R.W.2
Merigan, T.C.3
-
31
-
-
0029153101
-
Synergistic inhibition of HIV-1 reverse transcriptase DNA polymerase activity and virus replication in vitro by combinations of carboxanilide non-nucleoside compounds
-
(1995)
Biochemistry
, vol.34
, pp. 10106-10112
-
-
Fletcher, R.S.1
Arion, D.2
Borkow, G.3
-
33
-
-
0027214433
-
Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in different resistance pattern than does treatment with single-drug therapy
-
(1993)
J Virol
, vol.67
, pp. 5353-5359
-
-
Balzarini, J.1
Karlsson, A.2
Perez-Perez, M.J.3
-
39
-
-
0028099251
-
Resistance of HIV-1 reverse transcriptase against [2′,5′-bis-O-(tert-butyldimethylsily-3′-spiro-5″ -(4″-amino-1″, 2″-oxathiole-2″, 2″-dioxide)] (TIBO) derivatives is determined by the mutation Glu138-Lys on the p51 subunit
-
(1994)
J Biol Chem
, vol.269
, pp. 25255-25258
-
-
Jonckheere, H.1
Taymans, J.M.2
Balzarini, J.3
-
43
-
-
0033281851
-
Failure of HIV-1 protease inhibitors to fully suppress viral replication. Implications for salvage therapy
-
(1999)
Adv Exptl Med Biol
, vol.458
, pp. 175-182
-
-
Deeks, S.G.1
-
46
-
-
0032708315
-
High-dose saquinavir plus ritonavir: Long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response
-
(1999)
J AIDS
, vol.22
, pp. 132-138
-
-
Parades, R.1
Puig, T.2
Amo, A.3
-
47
-
-
0033601891
-
Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy
-
(1999)
Eur J Med Res
, vol.4
, pp. 54-58
-
-
Reiser, M.1
Salzberger, B.2
Steipel, A.3
-
48
-
-
0032700205
-
Antiretroviral therapy in 1999 for antiretroviral-naive individuals with HIV infection
-
(1999)
AIDS
, vol.13
, Issue.SUPPL. 1
-
-
Fischl, M.A.1
-
51
-
-
0028039607
-
Generation of multiple drug resistance by sequential in vitro passage of the Human Immunodeficiency Virus type 1
-
(1994)
Arch Virol
, vol.36
, pp. 111-122
-
-
Gao, Q.1
Gu, Z.2
Salomon, H.3
-
55
-
-
0030879818
-
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analysis
-
(1997)
J Virol
, vol.71
, pp. 8893-8898
-
-
Descamps, D.1
Collin, G.2
Letourneur, F.3
Apetrei, C.4
Damond, F.5
Loussert-Ajaka, I.6
Simon, F.7
Saragosti, S.8
Brun-Vezinet, F.9
-
56
-
-
0028172345
-
Locations of anti-AIDS drug binding sites and resistance mutations in three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance
-
(1994)
J Molec Biol
, vol.243
, pp. 369-387
-
-
Tantillo, C.1
Ding, A.2
Jacobs-Molina, R.3
-
57
-
-
0031957561
-
Human Immunodeficiency Virus type 1 subtype F reverse transcriptase sequence and drug susceptibility
-
(1998)
J Virol
, vol.72
, pp. 3534-3538
-
-
Apetrei, C.1
Descamps, D.2
Collin, G.3
Loussert-Ajaka, I.4
Damond, F.5
Duca, M.6
Simon, F.7
Brun-Vezinet, F.8
-
59
-
-
0032564526
-
Variations in HIV-1 pol gene associated with reduced sensitivity to anti-retroviral drugs in treatment-naïve patients
-
(1998)
AIDS
, vol.12
, pp. 2369-2375
-
-
Birk, B.1
Sonnerborg, A.2
-
62
-
-
0002117071
-
Genotyping and phenotyping analysis of B and non-B HIV-1 subtypes from Brazilian patients under HAART
-
Abstract 164
-
(2000)
Antiviral Ther
, vol.5
, Issue.SUPPL. 3
, pp. 128
-
-
Caride, E.1
Hertogs, K.2
Larder, B.3
Dehertogh, P.4
Brindeiro, R.5
Machado, E.6
De Sa, C.A.7
Eyer-Silva, W.A.8
Sion, F.S.9
Passioni, L.F.10
Menezes, J.A.11
Calazans, A.R.12
Tanuri, A.13
-
63
-
-
0002117073
-
Impact of HIV-1 subtype on NNRTI resistance mutations
-
Abstract 163
-
(2000)
Antiviral Ther
, vol.5
, Issue.SUPPL. 3
, pp. 128
-
-
Pillay, D.1
Sinka, K.2
Rice, P.3
Peters, B.4
Clarke, J.5
Workman, J.6
Evans, B.7
Cane, P.A.8
-
70
-
-
0002674645
-
Final results of CPCRA 046: A pilot study of antiretroviral management based on plasma genotypic antiretroviral resistance testing (GART) in patients failing antiretroviral therapy
-
(1999)
Antiviral Ther
, vol.4
, Issue.SUPPL. 1
-
-
Baxter, J.D.1
Mayers, D.2
Wentworth, D.N.3
-
73
-
-
0034105783
-
HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the women and infants transmission study
-
The Women and Infants Transmission Study Group
-
(2000)
AIDS
, vol.14
, Issue.3
, pp. 263-271
-
-
Welles, S.L.1
Pitt, J.2
Colgrove, R.3
McIntosk, K.4
Chung, P.H.5
Colson, A.6
Lockman, S.7
Fowler, M.G.8
Hanson, C.9
Landeman, S.10
Moye, J.11
Rich, K.C.12
Zorilla, C.13
Japour, J.A.14
-
74
-
-
0035291066
-
International perspectives on antiretroviral resistance. Nucleoside reverse transcriptase inhibitor resistance
-
(2001)
J Acquir Immune Defic Syndr
, vol.26
, Issue.SUPPL. 1
-
-
Loveday, C.1
-
77
-
-
0035292858
-
International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance
-
(2001)
J Acquir Immune Defic Syndr
, vol.26
, Issue.SUPPL. 1
-
-
Deeks, S.G.1
-
78
-
-
0035037383
-
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy
-
(2001)
J Virol
, vol.75
, Issue.11
, pp. 4999-5008
-
-
Bacheler, L.1
Jeffrey, S.2
Hanna, G.3
D'Aquila, R.4
Wallace, L.5
Logue, K.6
Cordova, B.7
Hertogs, K.8
Larder, B.9
Buckery, R.10
Baker, D.11
Gallagher, K.12
Scarnati, H.13
Tritch, R.14
Rizzo, C.15
-
79
-
-
0034909925
-
Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients
-
(2001)
J Virol
, vol.75
, Issue.16
, pp. 7462-7469
-
-
Kempf, D.J.1
Isaacson, J.D.2
King, M.S.3
Brun, S.C.4
Xu, Y.5
Real, K.6
Bernstein, B.M.7
Japour, A.J.8
Sun, E.9
Rode, R.A.10
-
80
-
-
0033995190
-
HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy
-
(2000)
AIDS
, vol.14
, Issue.2
, pp. 163-171
-
-
Miller, V.1
Ait-Khaled, M.2
Stone, C.3
Griffin, P.4
Mesogiti, D.5
Cutrell, A.6
Harrigan, R.7
Staszewski, S.8
Katlama, C.9
Pearce, G.10
Tisdale, M.11
-
81
-
-
0034088720
-
Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy
-
CNA2001 Investigative Group
-
(2000)
J Infect Dis
, vol.181
, Issue.3
, pp. 912-920
-
-
Harrigan, P.R.1
Stone, C.2
Griffin, P.3
Najera, I.4
Bloor, S.5
Kemp, S.6
Tisdale, M.7
Larder, B.8
-
82
-
-
0034069732
-
The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: Results from a randomized, double-blind, trial
-
CNA3002 European Study Team
-
(2000)
AIDS
, vol.14
, Issue.7
, pp. 781-789
-
-
Katiama, C.1
Clotet, B.2
Plettenberg, A.3
Jost, J.4
Arasteh, K.5
Bernasconi, E.6
Jeantils, V.7
Cutrell, A.8
Stone, C.9
Ait-Khaled, M.10
Purdon, S.11
-
85
-
-
0033635835
-
Prevention of perinatal HIV infection. What do we know? Where should future research go?
-
(2000)
Ann NY Acad Sci
, vol.918
, pp. 45-52
-
-
Fowler, M.G.1
-
86
-
-
0033523454
-
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
-
(1999)
Lancet
, vol.354
, pp. 795-802
-
-
Guay, L.A.1
Musoke, P.2
Fleming, T.3
-
87
-
-
0033576816
-
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
-
Study 006 Team
-
(1999)
N Engl J Med
, vol.341
, Issue.25
, pp. 1865-1873
-
-
Staszewski, S.1
Morales-Ramirez, J.2
Tashima, K.T.3
Rachlis, A.4
Skiest, D.5
Stanford, J.6
Stryker, R.7
Johnson, P.8
Labriola, D.F.9
Farina, D.10
Manion, D.J.11
Ruiz, N.M.12
-
88
-
-
0035880929
-
Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks
-
(2001)
J Acquir Immune Defic Syndr
, vol.27
, Issue.5
, pp. 459-462
-
-
Rey, D.1
Schmitt, M.P.2
Partisani, M.3
Hess-Kempf, G.4
Krantz, V.5
De Mautort, E.6
Bernard-Henry, C.7
Priester, M.8
Cheneau, C.9
Lang, J.M.10
-
89
-
-
0032565098
-
For the INCAS Study Group: A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. The INCAS trial
-
(1998)
JAMA
, vol.279
, pp. 930-937
-
-
Montaner, J.S.G.1
Reiss, P.2
Cooper, D.3
-
91
-
-
0035138694
-
The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy
-
(2001)
Drugs
, vol.61
, Issue.1
, pp. 19-26
-
-
Moyle, G.1
-
94
-
-
0034523865
-
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure
-
(2000)
AIDS
, vol.14
, Issue.18
, pp. 2857-2867
-
-
Miller, V.1
Sabin, C.2
Hertogs, K.3
Bloor, S.4
Martinez-Picado, J.5
D'Aquila, R.6
Larder, B.7
Lutz, T.8
Gute, P.9
Weidmann, E.10
Rabenau, H.11
Phillips, A.12
Staszewski, S.13
-
97
-
-
0035115259
-
Structured treatment interruption in HIV infection
-
(2001)
AIDS Read
, vol.11
, Issue.2
, pp. 99-102
-
-
Benson, C.A.1
|